112 related articles for article (PubMed ID: 12960835)
1. Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence.
Harwell JI; Flanigan TP; Mitty JA; Macalino GE; Caliendo AM; Ingersoll J; Stenzel MS; Carpenter CC; Cu-Uvin S
AIDS; 2003 Sep; 17(13):1990-3. PubMed ID: 12960835
[TBL] [Abstract][Full Text] [Related]
2. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
[TBL] [Abstract][Full Text] [Related]
3. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
[TBL] [Abstract][Full Text] [Related]
4. Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months.
Cu-Uvin S; Snyder B; Harwell JI; Hogan J; Chibwesha C; Hanley D; Ingersoll J; Kurpewski J; Mayer KH; Caliendo AM
J Acquir Immune Defic Syndr; 2006 Aug; 42(5):584-7. PubMed ID: 16837866
[TBL] [Abstract][Full Text] [Related]
5. Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study.
Launay O; Tod M; Tschöpe I; Si-Mohamed A; Bélarbi L; Charpentier C; Goujard C; Taburet AM; Lortholary O; Leroy V; Bélec L;
Antivir Ther; 2011; 16(6):843-52. PubMed ID: 21900716
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.
Graham SM; Jalalian-Lechak Z; Shafi J; Chohan V; Deya RW; Jaoko W; Mandaliya KN; Peshu NM; Overbaugh J; McClelland RS
J Acquir Immune Defic Syndr; 2012 Aug; 60(5):511-8. PubMed ID: 22592588
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1.
Kovacs A; Chan LS; Chen ZC; Meyer WA; Muderspach L; Young M; Anastos K; Levine AM
J Acquir Immune Defic Syndr; 1999 Oct; 22(2):124-31. PubMed ID: 10843525
[TBL] [Abstract][Full Text] [Related]
8. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women.
Uvin SC; Caliendo AM
Obstet Gynecol; 1997 Nov; 90(5):739-43. PubMed ID: 9351756
[TBL] [Abstract][Full Text] [Related]
9. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.
Low AJ; Konate I; Nagot N; Weiss HA; Kania D; Vickerman P; Segondy M; Mabey D; Pillay D; Meda N; van de Perre P; Mayaud P;
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):237-45. PubMed ID: 24226060
[TBL] [Abstract][Full Text] [Related]
10. Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.
Fiscus SA; Cu-Uvin S; Eshete AT; Hughes MD; Bao Y; Hosseinipour M; Grinsztejn B; Badal-Faesen S; Dragavon J; Coombs RW; Braun K; Moran L; Hakim J; Flanigan T; Kumarasamy N; Campbell TB;
Clin Infect Dis; 2013 Jul; 57(2):290-7. PubMed ID: 23532477
[TBL] [Abstract][Full Text] [Related]
11. HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.
Prazuck T; Chaillon A; Avettand-Fènoël V; Caplan AL; Sayang C; Guigon A; Niang M; Barin F; Rouzioux C; Hocqueloux L
PLoS One; 2013; 8(8):e69686. PubMed ID: 23990886
[TBL] [Abstract][Full Text] [Related]
12. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
Tuomala RE; O'Driscoll PT; Bremer JW; Jennings C; Xu C; Read JS; Matzen E; Landay A; Zorrilla C; Blattner W; Charurat M; Anderson DJ;
J Infect Dis; 2003 Feb; 187(3):375-84. PubMed ID: 12552421
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.
Meditz AL; Palmer C; Predhomme J; Searls K; Kerr B; Seifert S; Caraway P; Gardner EM; MaWhinney S; Anderson PL
AIDS Res Hum Retroviruses; 2015 Oct; 31(10):1015-22. PubMed ID: 26059647
[TBL] [Abstract][Full Text] [Related]
14. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.
Haubrich RH; Little SJ; Currier JS; Forthal DN; Kemper CA; Beall GN; Johnson D; Dubé MP; Hwang JY; McCutchan JA
AIDS; 1999 Jun; 13(9):1099-107. PubMed ID: 10397541
[TBL] [Abstract][Full Text] [Related]
15. Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up.
Clevenbergh P; Durant J; Halfon P; del Giudice P; Mondain V; Montagne N; Schapiro JM; Boucher CA; Dellamonica P
Antivir Ther; 2000 Mar; 5(1):65-70. PubMed ID: 10846595
[TBL] [Abstract][Full Text] [Related]
16. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective.
Idoko JA; Agbaji O; Agaba P; Akolo C; Inuwa B; Hassan Z; Akintunde L; Badung B; Muazu M; Danang M; Imade G; Sankale JL; Kanki P
Int J STD AIDS; 2007 Nov; 18(11):760-3. PubMed ID: 18005510
[TBL] [Abstract][Full Text] [Related]
17. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.
Gifford AL; Bormann JE; Shively MJ; Wright BC; Richman DD; Bozzette SA
J Acquir Immune Defic Syndr; 2000 Apr; 23(5):386-95. PubMed ID: 10866231
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.
Kwara A; Delong A; Rezk N; Hogan J; Burtwell H; Chapman S; Moreira CC; Kurpewski J; Ingersoll J; Caliendo AM; Kashuba A; Cu-Uvin S
Clin Infect Dis; 2008 Mar; 46(5):719-25. PubMed ID: 18220480
[TBL] [Abstract][Full Text] [Related]
19. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children.
Horneff G; Adams O; Wahn V
AIDS; 1998 Mar; 12(5):489-94. PubMed ID: 9543447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
